Bio-based surfactants from renewable waste streams for the circular economy
PureSurf aims to develop high-performance bio-based surfactants from renewable waste streams, enhancing sustainability in industries while maintaining economic competitiveness.
Projectdetails
Introduction
With climate and environmental concerns topping the global agenda, industries across all sectors are under tremendous pressure to rapidly change their existing fossil-based practices by shifting toward cleaner, greener, more sustainable (in one word: future fit) solutions in business and production, while maintaining economic competitiveness internationally.
Market Overview
Surfactants (17 million t/year market globally) are omnipresent in key industrial segments such as:
- Detergents
- Personal care
- Coatings
- Agrochemicals
- Pharmaceuticals
Companies are actively looking to shift toward bio-based alternatives while maintaining product performance. Surprisingly, the valorization of renewable waste streams occurring in large quantities for making novel surfactants has not been adequately exploited so far. The reason for this is the lack of fundamentally new technologies in this area.
Project Goals
With the credo: Superior performance and clean conscience, PureSurf introduces ground-breaking manufacturing concepts to produce novel high-performance bio-based surfactants from currently underutilized renewable waste streams. In the ERC PoC PURE project, novel green surfactants were obtained by green and scalable synthetic pathways, resulting in 2 patent applications.
Validation Activities
Building on this, the PureSurf validation activities will include:
- Upscaling at least one gemini anionic and one zwitterionic surfactant structure to 1 kg to validate their properties, using clean starting materials.
- Upscaling (to 5 kg, TRL5-6) at least one selected example using industrial waste streams.
- Determining properties, ecotoxicity, biodegradability (also anaerobic), as well as performance in industrial applications.
- Critically comparing to existing surfactants, establishing a business case, and preparing an investor-ready technology.
Team and Vision
The PureSurf team, consisting of leading experts in green chemistry, engineering, and business with a strong industrial network, aims to establish a spin-off company and become a frontrunner in bio-based surfactants.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.475.998 |
Totale projectbegroting | € 2.475.998 |
Tijdlijn
Startdatum | 1-5-2022 |
Einddatum | 31-10-2025 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- UNIVERSITAET GRAZpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Transition
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Targeting cardiac fibrosis with next generation RNA therapeuticsFIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness. | EIC Transition | € 2.499.482 | 2022 | Details |
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationSThe NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring. | EIC Transition | € 2.497.750 | 2022 | Details |
Predictive REagent-Antibody Replacement Technology stage 2-TranslationPRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment. | EIC Transition | € 800.000 | 2022 | Details |
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stageDeveloping a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships. | EIC Transition | € 2.499.810 | 2022 | Details |
Targeting cardiac fibrosis with next generation RNA therapeutics
FIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness.
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationS
The NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring.
Predictive REagent-Antibody Replacement Technology stage 2-Translation
PRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment.
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stage
Developing a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Eco conversion of lower grade PET and mixed recalcitrant PET plastic waste into high performing biopolymersECOPLASTIC aims to transform unrecyclable PET plastic waste into high-performance bioplastics through innovative depolymerization and biopolymer production, promoting true circularity and sustainability. | EIC Pathfinder | € 3.045.502 | 2022 | Details |
Accelerating biofilm Matrix dispersion with Deep Eutectic SolventsThis project aims to develop and commercialize a sustainable NADES-based solution for biofouling mitigation in water treatment, outperforming existing products in safety and effectiveness. | ERC POC | € 150.000 | 2024 | Details |
Afvalstromen van olieachtige producten omvormen tot hoogwaardige grondstoffen voor reinigings- en verzorgingsproductenSirius onderzoekt de haalbaarheid van het hergebruik van organische reststromen voor de productie van duurzame reinigings- en verzorgingsproducten, ter vermindering van CO2-uitstoot en ontbossing. | MIT Haalbaarheid | € 20.000 | 2023 | Details |
GREEN PUGREEN PU onderzoekt biogebaseerde vervangers voor isocyanaten in duurzame PU-isolatieschuimen, met als doel de circulaire economie te bevorderen en schadelijke stoffen te verminderen. | MIT Haalbaarheid | € 20.000 | 2022 | Details |
Eco conversion of lower grade PET and mixed recalcitrant PET plastic waste into high performing biopolymers
ECOPLASTIC aims to transform unrecyclable PET plastic waste into high-performance bioplastics through innovative depolymerization and biopolymer production, promoting true circularity and sustainability.
Accelerating biofilm Matrix dispersion with Deep Eutectic Solvents
This project aims to develop and commercialize a sustainable NADES-based solution for biofouling mitigation in water treatment, outperforming existing products in safety and effectiveness.
Afvalstromen van olieachtige producten omvormen tot hoogwaardige grondstoffen voor reinigings- en verzorgingsproducten
Sirius onderzoekt de haalbaarheid van het hergebruik van organische reststromen voor de productie van duurzame reinigings- en verzorgingsproducten, ter vermindering van CO2-uitstoot en ontbossing.
GREEN PU
GREEN PU onderzoekt biogebaseerde vervangers voor isocyanaten in duurzame PU-isolatieschuimen, met als doel de circulaire economie te bevorderen en schadelijke stoffen te verminderen.